These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29312499)

  • 1. LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.
    Jing W; Vaziri ND; Nunes A; Suematsu Y; Farzaneh T; Khazaeli M; Moradi H
    Am J Transl Res; 2017; 9(12):5473-5484. PubMed ID: 29312499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease.
    Suematsu Y; Jing W; Nunes A; Kashyap ML; Khazaeli M; Vaziri ND; Moradi H
    J Card Fail; 2018 Apr; 24(4):266-275. PubMed ID: 29325796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor.
    Ushijima K; Ando H; Arakawa Y; Aizawa K; Suzuki C; Shimada K; Tsuruoka SI; Fujimura A
    Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats.
    Jing W; Nunes ACF; Farzaneh T; Khazaeli M; Lau WL; Vaziri ND
    J Pharmacol Exp Ther; 2018 Oct; 367(1):129-137. PubMed ID: 30093458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease.
    Mohany M; Ahmed MM; Al-Rejaie SS
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats.
    Hsu SJ; Huang HC; Chuang CL; Chang CC; Hou MC; Lee FY; Lee SD
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32252377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats.
    Mohany M; Alanazi AZ; Alqahtani F; Belali OM; Ahmed MM; Al-Rejaie SS
    PeerJ; 2020; 8():e9196. PubMed ID: 32596035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice.
    Suo Y; Yuan M; Li H; Zhang Y; Li Y; Fu H; Han F; Ma C; Wang Y; Bao Q; Li G
    Front Pharmacol; 2019; 10():1285. PubMed ID: 31736759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease.
    Vaziri ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli M; Zhao YY
    Free Radic Biol Med; 2015 Sep; 86():374-81. PubMed ID: 25930007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
    Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
    J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
    Cho KH; Kim HJ; Rodriguez-Iturbe B; Vaziri ND
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F106-13. PubMed ID: 19420110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice.
    Munkhjargal U; Fukuda D; Maeda J; Hara T; Okamoto S; Bavuu O; Yamamoto T; Sata M
    J Atheroscler Thromb; 2024 Apr; ():. PubMed ID: 38616113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.
    Jing W; Jabbari B; Vaziri ND
    Am J Transl Res; 2018; 10(7):2137-2147. PubMed ID: 30093950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
    Kim HJ; Vaziri ND
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.
    Chen DQ; Chen H; Chen L; Vaziri ND; Wang M; Li XR; Zhao YY
    Nephrol Dial Transplant; 2017 Jul; 32(7):1154-1166. PubMed ID: 28339984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LCZ696 Ameliorates Isoproterenol-Induced Acute Heart Failure in Rats by Activating the Nrf2 Signaling Pathway.
    Hou M; Lu L; Wu X; Liu H
    Appl Bionics Biomech; 2022; 2022():6077429. PubMed ID: 35528528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.
    Yang CC; Yip HK; Chen KH; Sun CK; Chen YT; Chai HT; Sung PH; Chiang HJ; Ko SF; Chung SY; Chen CH; Lin KC; Lin PY; Sheu JJ
    Am J Transl Res; 2017; 9(5):2548-2566. PubMed ID: 28560004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.
    Kim S; Kim SJ; Yoon HE; Chung S; Choi BS; Park CW; Shin SJ
    Int J Med Sci; 2015; 12(11):891-904. PubMed ID: 26640409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.